These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24079661)

  • 21. Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells.
    Reich M; Lesner A; Legowska A; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
    Mol Immunol; 2009 Sep; 46(15):2994-9. PubMed ID: 19615749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent progress in therapeutic applications of chalcones.
    Katsori AM; Hadjipavlou-Litina D
    Expert Opin Ther Pat; 2011 Oct; 21(10):1575-96. PubMed ID: 21711087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
    Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
    Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycosidase inhibitors: a patent review (2008-2013).
    Brás NF; Cerqueira NM; Ramos MJ; Fernandes PA
    Expert Opin Ther Pat; 2014 Aug; 24(8):857-74. PubMed ID: 24958352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substituted 4H-3,1-benzoxazine-4-one Derivatives as Inhibitors of Cathepsin G.
    Aliter KF; Al-Horani RA
    Med Chem; 2024 Apr; ():. PubMed ID: 38676528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinoxaline derivatives: a patent review (2006--present).
    González M; Cerecetto H
    Expert Opin Ther Pat; 2012 Nov; 22(11):1289-302. PubMed ID: 22971178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycogen phosphorylase inhibitors: a patent review (2008 - 2012).
    Gaboriaud-Kolar N; Skaltsounis AL
    Expert Opin Ther Pat; 2013 Aug; 23(8):1017-32. PubMed ID: 23627914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
    Dymock BW; See CS
    Expert Opin Ther Pat; 2013 Apr; 23(4):449-501. PubMed ID: 23367873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMPA receptor positive allosteric modulators: a patent review.
    Pirotte B; Francotte P; Goffin E; de Tullio P
    Expert Opin Ther Pat; 2013 May; 23(5):615-28. PubMed ID: 23405869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel thiazole derivatives: a patent review (2008 - 2012. Part 2).
    Leoni A; Locatelli A; Morigi R; Rambaldi M
    Expert Opin Ther Pat; 2014 Jul; 24(7):759-77. PubMed ID: 24745553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cathepsin S inhibitors: 2004-2010.
    Lee-Dutra A; Wiener DK; Sun S
    Expert Opin Ther Pat; 2011 Mar; 21(3):311-37. PubMed ID: 21342054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel FabH inhibitors: a patent and article literature review (2000--2012).
    Luo Y; Yang YS; Fu J; Zhu HL
    Expert Opin Ther Pat; 2012 Nov; 22(11):1325-36. PubMed ID: 22998551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).
    Marzaro G; Guiotto A; Chilin A
    Expert Opin Ther Pat; 2012 Mar; 22(3):223-52. PubMed ID: 22404097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel pharmacological modulators of autophagy and therapeutic prospects.
    Bischoff P; Josset E; Dumont FJ
    Expert Opin Ther Pat; 2012 Sep; 22(9):1053-79. PubMed ID: 22860892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel therapies for glaucoma: a patent review 2007 - 2011.
    Carta F; Supuran CT; Scozzafava A
    Expert Opin Ther Pat; 2012 Jan; 22(1):79-88. PubMed ID: 22191414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface plasmon resonance imaging biosensor for cathepsin G based on a potent inhibitor: development and applications.
    Gorodkiewicz E; Sieńczyk M; Regulska E; Grzywa R; Pietrusewicz E; Lesner A; Lukaszewski Z
    Anal Biochem; 2012 Apr; 423(2):218-23. PubMed ID: 22369897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel prostaglandin receptor modulators: a patent review (2002 - 2012) - part I: non-EP receptor modulators.
    Lamers C; Flesch D; Schubert-Zsilavecz M; Merk D
    Expert Opin Ther Pat; 2013 Jan; 23(1):47-77. PubMed ID: 23151189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine and its derivatives: a patent review (2009 - 2012).
    Singh IP; Mahajan S
    Expert Opin Ther Pat; 2013 Feb; 23(2):215-31. PubMed ID: 23231038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoclast differentiation inhibitors: a patent review (2008 - 2012).
    Kim SH; Moon SH
    Expert Opin Ther Pat; 2013 Dec; 23(12):1591-610. PubMed ID: 24093967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
    Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
    Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.